Intervention Review

You have free access to this content

Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults

  1. Mattias Linde1,*,
  2. Wim M Mulleners2,
  3. Edward P Chronicle3,
  4. Douglas C McCrory4,5

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 24 JUN 2013

Assessed as up-to-date: 15 JAN 2013

DOI: 10.1002/14651858.CD010611


How to Cite

Linde M, Mulleners WM, Chronicle EP, McCrory DC. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010611. DOI: 10.1002/14651858.CD010611.

Author Information

  1. 1

    Norwegian University of Science and Technology, Department of Neuroscience, Trondheim, Norway

  2. 2

    Canisius Wilhelmina Ziekenhuis, Department of Neurology, Nijmegen, Netherlands

  3. 3

    University of Hawaii at Manoa, (Deceased) Department of Psychology, Manoa, USA

  4. 4

    Duke University Medical Center, Department of Medicine, Durham, NC, USA

  5. 5

    Durham Veterans Affairs Medical Center, Center for Health Services Research in Primary Care, Durham, NC, USA

*Mattias Linde, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. mattias.linde@ntnu.no.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JUN 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Charly Gaul, Hans-Christoph Diener, Ulrich Danesch, Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial, The Journal of Headache and Pain, 2015, 16, 1

    CrossRef

  2. 2
    Michel D Ferrari, Roselin R Klever, Gisela M Terwindt, Cenk Ayata, Arn M J M van den Maagdenberg, Migraine pathophysiology: lessons from mouse models and human genetics, The Lancet Neurology, 2015, 14, 1, 65

    CrossRef

  3. 3
    Mehmet Asim Bilen, Siqing Fu, Gerald S. Falchook, Chaan S. Ng, Jennifer J. Wheler, Maen Abdelrahim, Basak Erguvan-Dogan, David S. Hong, Apostolia M. Tsimberidou, Razelle Kurzrock, Aung Naing, Phase I trial of valproic acid and lenalidomide in patients with advanced cancer, Cancer Chemotherapy and Pharmacology, 2015, 75, 4, 869

    CrossRef

  4. 4
    Paul Edward Rolan, Understanding the pharmacology of headache, Current Opinion in Pharmacology, 2014, 14, 30

    CrossRef

  5. 5
    Mattias Linde, Wim M Mulleners, Edward P Chronicle, Douglas C McCrory, Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults, The Cochrane Library,
  6. 6
    Clare P Herd, Alexandra Sinclair, Natalie Ives, Caroline Rick, Julie Edwards, Carl E Clarke, Botulinum toxins for the prevention of migraine in adults, The Cochrane Library,
  7. 7
    Mattias Linde, Wim M Mulleners, Edward P Chronicle, Douglas C McCrory, Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults, The Cochrane Library,
  8. 8
    Mattias Linde, Wim M Mulleners, Edward P Chronicle, Douglas C McCrory, Topiramate for the prophylaxis of episodic migraine in adults, The Cochrane Library,
  9. 9
    Mattias Linde, Wim M Mulleners, Edward P Chronicle, Douglas C McCrory, Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults, The Cochrane Library,